Price of lupus drug decreases significantly after being listed on pharmaceutical benefits scheme

Views 7.9K

For thousands of patients, the cost of some vital medicines will come down significantly today, after being listed on the pharmaceutical benefits scheme. One of those is for a drug used to treat one the most common auto-immune diseases in the world, with nine out of ten patients being women, and rates especially high among first nations and Asian Australians.

Share This Video


Download

  
Report form